To create advanced products and technologies, that bring the results of basic science and needs of the NTI markets together improving the economic efficiency, life expectancy and people's quality of life.


BIOORGANIKA Consortium is a partnership of educational, scientific organizations and high-tech companies. The competencies of 28 leading industry organizations are involved in R&d (12 research projects, clinical and preclinical trials) and educational projects aimed at training of experts in the field of biotechnology and pharmaceutical technology.

There is a Review Board within the Consortium, which allows to provide expert opinion to the drugs being introduced to the Russian market.

BIOORGANIKA Consortium consists of 28 leading organizations, including

Research institutions such as Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Federal Budget Institution of Science State Research Center for Applied Microbiology&Biotechnology, Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences, Research Center of Neurology, Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, Institute of Gene Biology Russian Academy of Sciences and CIM;

A number of medical and clinical diagnostic associations, medical-pharmaceutical and scientific-technological entities such as PJSC Human Stem Cells Institute PJSC (HSCI), LLC GeneTechnology, LLC Pharmsynthez, Genetico, Kazan University, LLC Corporate Communication Center S-GROUP, LLC MC Development, Ferring Pharmaceuticals, The Center of Scientific Advice, Research Center of Neurology, The National Medical Research Center for Endocrinology, ESMAR, «Medsintez» plant, CIMAB S. A., Center of Scientific advice, Ferring Pharmaceuticals, State Scientific Center for Dermatovenereology and Cosmetology.

The largest educational research training centers such as Lomonosov Moscow state University, EF Sirius University and Higher School of Economics.